AI Verdict
KAPA has stronger fundamentals based on our AI analysis.
KBH vs KAPA Fundamental Comparison
| Metric | KBH | KAPA |
|---|---|---|
| Revenue | $1.1B | N/A |
| Net Income | $33.4M | $-5.4M |
| Net Margin | 3.1% | N/A |
| ROE | 0.9% | -85.9% |
| ROA | 0.5% | -83.3% |
| Current Ratio | N/A | 27.07x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $0.52 | $-0.30 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KBH vs KAPA: Frequently Asked Questions
Is KBH or KAPA a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KAPA has stronger fundamentals. KBH is rated SELL (72% confidence) while KAPA is rated SELL (85% confidence). This is not investment advice.
How does KBH compare to KAPA fundamentally?
KB HOME has ROE of 0.9% vs Kairos Pharma, LTD.'s -85.9%. Net margins are 3.1% vs N/A respectively.
Which stock pays higher dividends, KBH or KAPA?
KBH has a dividend yield of N/A or no dividend while KAPA has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KBH or KAPA for long term?
For long-term investing, consider that KBH has SELL rating with 72% confidence, while KAPA has SELL rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KBH vs KAPA?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KBH vs KAPA, the AI consensus favors KAPA based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.